Company Overview
Snapshot
Founded in September 2017, THERAPiN operates with 1–10 employees. The company has raised a total of $22 million across two funding rounds, reaching a Series A stage. THERAPiN focuses on developing, growing, and producing raw materials and premium cannabis products.
Business overview
THERAPiN is a Health Tech & Life Sciences company specializing in the development, cultivation, and production of cannabis-based products. The company focuses on creating raw materials and premium cannabis products for both medical and cosmetic applications. THERAPiN serves the international market, catering to patients, consumers, and pharmaceutical companies within the medical cannabis and broader pharmaceuticals sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is THERAPiN's primary business activity?
- THERAPiN develops, grows, and produces raw materials and premium cannabis products for medical and cosmetic use, targeting the international market.
- When was THERAPiN founded?
- THERAPiN was founded in September 2017.
- How much capital has THERAPiN raised to date?
- THERAPiN has raised a total of $22 million in funding.
- What is THERAPiN's current funding stage?
- THERAPiN is currently at the Series A funding stage, having raised $22 million across two funding rounds.
- In which sectors does THERAPiN primarily operate?
- THERAPiN operates primarily in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology, specifically Medical Cannabis.